Researchers continue to excited about the medication , a groundbreaking dual treatment showing remarkable data in early trials for size loss . It acts by targeting two pathways : GLP-1 and GIP, which , https://dianeybdo590127.dailyhitblog.com/46396848/this-new-hope-for-size-loss